Jeff Johnson
Stock Analyst at Baird
(4.74)
# 132
Out of 4,479 analysts
81
Total ratings
60.71%
Success rate
36.82%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Outperform | $116 → $118 | $86.51 | +36.40% | 14 | May 31, 2024 | |
| ALC Alcon | Maintains: Outperform | $95 → $104 | $88.79 | +17.13% | 6 | May 15, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $28 → $36 | $39.15 | -8.05% | 6 | May 3, 2024 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $19 | $16.34 | +16.28% | 3 | May 2, 2024 | |
| SYK Stryker | Maintains: Outperform | $367 → $378 | $334.30 | +13.07% | 5 | May 1, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $333 → $370 | $239.74 | +54.33% | 11 | Apr 25, 2024 | |
| PODD Insulet | Upgrades: Outperform | $180 → $238 | $197.19 | +20.70% | 8 | Dec 21, 2023 | |
| DXCM DexCom | Maintains: Outperform | $153 → $130 | $112.49 | +15.57% | 5 | Aug 21, 2023 | |
| ENOV Enovis | Maintains: Outperform | $67 → $70 | $44.71 | +56.56% | 2 | Aug 4, 2023 | |
| INMD InMode | Maintains: Outperform | $53 → $61 | $17.41 | +250.37% | 2 | Jul 28, 2023 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Outperform | $172 | $106.27 | +61.85% | 9 | Jun 28, 2023 | |
| HSIC Henry Schein | Downgrades: Neutral | $103 → $88 | $65.60 | +34.15% | 4 | Jun 14, 2022 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $78 → $67 | $24.44 | +174.14% | 5 | Feb 18, 2022 | |
| PDCO Patterson Companies | Upgrades: Outperform | n/a | $23.92 | - | 1 | Jan 3, 2017 |
The Cooper Companies
May 31, 2024
Maintains: Outperform
Price Target: $116 → $118
Current: $86.51
Upside: +36.40%
Alcon
May 15, 2024
Maintains: Outperform
Price Target: $95 → $104
Current: $88.79
Upside: +17.13%
Tandem Diabetes Care
May 3, 2024
Maintains: Neutral
Price Target: $28 → $36
Current: $39.15
Upside: -8.05%
Envista Holdings
May 2, 2024
Maintains: Neutral
Price Target: $22 → $19
Current: $16.34
Upside: +16.28%
Stryker
May 1, 2024
Maintains: Outperform
Price Target: $367 → $378
Current: $334.30
Upside: +13.07%
Align Technology
Apr 25, 2024
Maintains: Outperform
Price Target: $333 → $370
Current: $239.74
Upside: +54.33%
Insulet
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $197.19
Upside: +20.70%
DexCom
Aug 21, 2023
Maintains: Outperform
Price Target: $153 → $130
Current: $112.49
Upside: +15.57%
Enovis
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $44.71
Upside: +56.56%
InMode
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $17.41
Upside: +250.37%
Zimmer Biomet Holdings
Jun 28, 2023
Reiterates: Outperform
Price Target: $172
Current: $106.27
Upside: +61.85%
Henry Schein
Jun 14, 2022
Downgrades: Neutral
Price Target: $103 → $88
Current: $65.60
Upside: +34.15%
DENTSPLY SIRONA
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $24.44
Upside: +174.14%
Patterson Companies
Jan 3, 2017
Upgrades: Outperform
Price Target: n/a
Current: $23.92
Upside: -